Nail infection by Aspergillus ochraceopetaliformis

Medical Mycology

Volumn 47, Issue 6, 2009, Pages 658-662

  Brasch, J ^a   Varga, J ^b,c   Jensen, J M ^a   Egberts, F ^a   Tintelnot, K ^d  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

^c UNIVERSITY OF SZEGED   (Hungary)

^d ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Antimycotics; Aspergillus ochraceopetaliformis; Genotype; Onychomycosis; Phenotype; Toxins

Indexed keywords

1,4 NAPHTHOQUINONE DERIVATIVE; AGAR; ANTIBIOTIC AGENT; BETA TUBULIN; CALMODULIN; CICLOPIROXOLAMINE; CYCLOHEXIMIDE; GLUCOSE; HYALIN; INTERNAL TRANSCRIBED SPACER; ITRACONAZOLE; KERATIN; NUCLEOTIDE; OCHRATOXIN; PENICILLIC ACID; POTASSIUM HYDROXIDE; RIBOSOME DNA; TERBINAFINE; WATER;

ADULT; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; ASPERGILLUS FLOCCULOSUS; ASPERGILLUS OCHRACEOPETALIFORMIS; ASPERGILLUS OCHRACEUS; AUTOCLAVE; CASE REPORT; CLIMATE; CLINICAL EXAMINATION; CONIDIUM; CONTAMINATION; DERMATOPHYTE; DESERT; DISEASE COURSE; DISEASE DURATION; DNA SEQUENCE; DRUG DOSE REDUCTION; EPSILOMETER TEST; FEMALE; FOOT; FUNGAL COLONIZATION; FUNGAL MORPHOLOGY; FUNGAL STRAIN; FUNGUS CULTURE; FUNGUS GROWTH; FUNGUS HYPHAE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; GENE AMPLIFICATION; GENETIC TRAIT; GERMANY; HISTOLOGY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INOCULATION; METABOLITE; MINIMUM INHIBITORY CONCENTRATION; MYCELIUM; NAIL COLOR DEFECT; NUCLEOTIDE SEQUENCE; PHENOTYPE; PIGMENTATION; RHODOTORULA; SKIN; SOUTH AMERICA; SPECIES IDENTIFICATION; SYSTEMIC THERAPY; TEMPERATURE; THALLUS; TOENAIL ONYCHOMYCOSIS; TRAVEL; TREATMENT DURATION; WEATHER;

ANTIFUNGAL AGENTS; ASPERGILLUS; FEMALE; FOOT DERMATOSES; HUMANS; MIDDLE AGED; NAPHTHALENES; ONYCHOMYCOSIS; PYRIDONES; SPORES, FUNGAL;

ASPERGILLUS OCHRACEOPETALIFORMIS; FUNGI;

EID: 70849124578     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780902803032     Document Type: Article

References (17)

1. Hay R. Literature review. Onychomycosis. J Eur Acad Dermatol Venereol 2005; 19(Suppl. 1): 1-7.
2. Iorizzo M, Piraccini BM, Tosti A. New fungal nail infections. Curr Opin Infect Dis 2007; 20: 142-145.
3. Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution. Antifungal susceptibility testing of filamentous fungi; CLSI document 38-A.Wayne (PA): CLSI; 2002
4. White TJ, Bruns T, Lee S, et al. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ (eds). PCR Protocols: A Guide to Methods and Applications. San Diego, CA: Academic Press, 1990: 315-322.
5. Glass NL, Donaldson G. Development of primer sets designed for use with the PCR to amplify conserved genes from filamentous ascomycetes. Appl Environ Microbiol 1995; 61: 1323-1330.
6. Hong SB, Cho HS, Shin HD, Frisvad JC, Samson RA. Novel Neosartorya species isolated from soil in Korea. Int J Syst Evol Microbiol 2005; 56: 477-486.
7. Peterson SW. Phylogenetic analyses of Aspergillus species using DNA sequences from four loci. Mycologia 2008; 100: 205-226.
8. Frisvad JC, Frank JM, Houbraken JAMP, Kuijpers AFA, Samson RA. New ochratoxin producing species of Aspergillus section Circumdati. Stud Mycol 2004; 50: 23-43.
9. Gianni C, Romano C. Clinical and histological aspects of toenail onychomycosis caused by Aspergillus spp.: 34 cases treated with weekly intermittent terbinafine. Dermatology 2004; 209: 104-109.
10. Balajee SA, Marr KA. Phenotypic and genotypic identification of human pathogenic aspergilli. Future Microbiol 2006; 1: 435-445.
11. de Valk HA, Klaassen CH, Meis JF. Molecular typing of Aspergillus species. Mycoses 2008; 51: 463-476.
12. Batista AC, Maia da Silva H. Alguns Aspergillus contaminantes de culturas. Anais da Sociedade de Biologia de Pernambuco 1957; 15: 181-237.
13. Novey HS, Wells ID. Allergic bronchopulmonary aspergillosis caused by Aspergillus ochraceus. Am J Clin Pathol 1978; 70: 840-843.
14. Wierzbicka M, Podsiadlo B, Janczarski M. [Invasive pulmonary aspergillosis caused by Aspergillus ochraceus]. Pneumonol Alergol Pol 1997; 65: 254-260.
15. Bassiouny A, Maher A, Bucci TJ, Moaward MK, Hendawy DS. Non invasive antromycosis (diagnosis and treatment). J Laryngol Otol 1982; 96: 215-228.
16. Harima N, Inoue T, Kubota T, et al. A case of otomycosis caused by Aspergillus sclerotiorum. J Dermatol 2004; 31: 949-950.
17. Feuilhade de Chauvin M, de Bievre C. Onyxis et perionyxis a Aspergillus sclerotiorum. Bull Fr Mycol Med 1985; 14: 77-79.